1558. A Population Pharmacokinetic Model for Posaconazole Intravenous Solution and Oral Powder for Suspension Formulations in Pediatric Patients With Neutropenia

por Winchell, Gregory A, de Greef, Rik, Wrishko, Rebecca E, Mangin, Eric, Waskin, Hetty, Bruno, Christopher
Publicado 2019

Safety, Tolerability, and Pharmacokinetics (PK) of Posaconazole (POS) Intravenous (IV) Solution and Oral Powder for Suspension in Children With Neutropenia

por Groll, Andreas H, Abdel-Azim, Hisham, Lehrnbecher, Thomas, Steinbach, William, Murray, RoseAnn, Paschke, Amanda, Mangin, Eric, Winchell, Gregory A, Bruno, Christopher J
Publicado 2017

Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal Infections

por Wu, Depei, Mi, Yingchang, Weng, Jianyu, Zhuang, Junling, Ke, Xiaoyan, Wang, Chun, Liu, Kaiyan, Martinho, Monika, Winchell, Gregory A., Zang, Yanqiao, Xu, Lianzhe
Publicado 2022

Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis

por Maertens, Johan A., Rahav, Galia, Lee, Dong-Gun, Haider, Shariq, Ramirez-Sanchez, Isabel Cristina, Klimko, Nikolai, Ponce-de-León, Alfredo, Han, Seongah, Wrishko, Rebecca, Winchell, Gregory A., Grandhi, Anjana, Waskin, Hetty
Publicado 2023

Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)

por Sferra, Thomas J, Merta, Tomas, Neely, Michael, Murta de Oliveira, Claudia, Lassaletta, Alvaro, Fortuny Guasch, Claudia, Dorr, Mary Beth, Winchell, Gregory, Su, Feng-Hsiu, Perko, Sarah, Fernsler, Doreen, Waskin, Hetty, Holden, Stephen R
Publicado 2023